Biotie: Change in the number of votes

BIOTIE THERAPIES CORP.                  Stock Exchange Release            3 April 2014 at 2.45 pm

Biotie: Change in the number of votes

Biotie Therapies Corp. ("Biotie" or the "Company") has conveyed Biotie shares held as treasury shares, that were issued on 2 January 2014, pursuant to the Stock Option Plan 2011 and the Equity Incentive Plan 2011 as follows:

Shares conveyedCumulative shares conveyed since 2 January 2014Remaining shares to be conveyed 752,500 1,091,250 2,230,410

Under the Stock Option Plan 2011, the owners of the stock options may subscribe for a maximum total of 7,401,000 new shares in the Company or existing shares held by the Company. A total of 427,500 shares have been subscribed for during the period 28 February 2014 and 3 April 2014 and 427,500 of the treasury shares will be used for these share subscriptions. The subscription price of EUR 0.01 per share has been fully paid by the employee and the EUR 4,275 funds received will be credited to the Company's reserve for non-restricted equity.

The first vesting period of the Equity Incentive Plan 2011 ended on 5 January 2014, after which the Company's shares shall be delivered to employees on the basis of the granted share units. It was resolved pursuant to the authorization of the Annual General Meeting of the Shareholders to issue 325,000 existing treasury shares to the employees without consideration for the purposes of remunerating the employees pursuant to the terms and conditions of the Equity Incentive Plan 2011 and thus, there is an especially weighty financial reason to derogate from the pre-emptive right of the shareholders, as referred to in Chapter 9 Section 4(1) of the Companies Act (624/2006, as amended).

The conveyed shares previously held as treasury shares have not carried any voting rights. The conveyance does not affect the number of registered shares. After the conveyances the changes are as follows:

Increase in number of outstanding sharesTotal amount of
voting rightsNumber of the
Company's shares held
by the GroupTotal number
of registered
shares 752,500 447,305,198 8,727,200 456,032,398

Turku, 3 April 2014

Biotie Therapies Corp.
Timo Veromaa, President and CEO

For further information, please contact:
Virve Nurmi, Investor Relations Manager, Biotie Therapies Corp.
tel. +358 2 274 8900, e-mail: virve.nurmi@biotie.com

www.biotie.com
DISTRIBUTION:
NASDAQ OMX Helsinki Ltd
Main Media 

This announcement is distributed by Nasdaq OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Biotie Therapies Oyj via Globenewswire
HUG#1774201